BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thomson AB, Gupta M, Freeman HJ. Use of the tumor necrosis factor-blockers for Crohn's disease. World J Gastroenterol 2012; 18(35): 4823-4854 [PMID: 23002356 DOI: 10.3748/wjg.v18.i35.4823]
URL: https://www.wjgnet.com/1007-9327/full/v18/i35/4823.htm
Number Citing Articles
1
Ian Brown, Marian Priyanthi Kumarasinghe. Granulomas in the gastrointestinal tract: deciphering the Pandora’s boxVirchows Archiv 2018; 472(1): 3 doi: 10.1007/s00428-017-2210-3
2
Joo Hye Song, Sung Noh Hong, Jung Eun Lee, Kyunga Kim, Tae Jun Kim, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim. C-Reactive protein reduction rate following initiation of anti-tumor necrosis factor α induction therapy predicts secondary loss of response in patients with Crohn's diseaseScandinavian Journal of Gastroenterology 2019; 54(7): 876 doi: 10.1080/00365521.2019.1638962
3
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2019; 2019(11) doi: 10.1002/14651858.CD012878.pub2
4
Yeonsil Yu, Eun Mi Song, Ko Eun Lee, Yang-Hee Joo, Seong-Eun Kim, Chang Mo Moon, Ha Yeong Kim, Sung-Ae Jung, Inho Jo, Hossam M. M. Arafa. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitisPLOS ONE 2017; 12(8): e0183141 doi: 10.1371/journal.pone.0183141
5
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD012878
6
Haimavati Rammohan, C. Ganesh Pai. Shrinking Indications for Azathioprine in Crohn's Disease: A Conclusion too Premature?Gastroenterology 2014; 146(3): 866 doi: 10.1053/j.gastro.2013.10.071
7
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine2019; : 67 doi: 10.1007/978-3-319-72303-7_9
8
Ana Echarri, Virginia Ollero, Manuel Barreiro-de Acosta, Alberto Fernández-Villaverde, Vicent Hernández, Aurelio Lorenzo, Santos Pereira, Daniel Carpio, Javier Castro. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(4): 430 doi: 10.1097/MEG.0000000000000296
9
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Giovanni Toscano, Francesco Cimino, Antonella Saija. In Vitro Protective Effects of a Standardized Extract From Cynara Cardunculus L. Leaves Against TNF-α-Induced Intestinal InflammationFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.809938
10
Alaa S. Awad, Hanning You, Ting Gao, Timothy K. Cooper, Sergei A. Nedospasov, Jean Vacher, Patrick F. Wilkinson, Francis X. Farrell, W. Brian Reeves. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injuryKidney International 2015; 88(4): 722 doi: 10.1038/ki.2015.162
11
Daniela Graf, Jennifer M. Monk, Wenqing Wu, Hannah R. Wellings, Lindsay E. Robinson, Krista A. Power. Red lentil supplementation reduces the severity of dextran sodium sulfate-induced colitis in C57BL/6 male miceJournal of Functional Foods 2020; 64: 103625 doi: 10.1016/j.jff.2019.103625
12
Yoo Min Lee, Ben Kang, Yoon Lee, Mi Jin Kim, Yon Ho Choe. Infliximab “Top-Down” Strategy is Superior to “Step-Up” in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn DiseaseJournal of Pediatric Gastroenterology & Nutrition 2015; 60(6): 737 doi: 10.1097/MPG.0000000000000711
13
Geert D'Haens, William J Sandborn, Jean Frederic Colombel, Paul Rutgeerts, Kurt Brown, Hadas Barkay, Anat Sakov, Asi Haviv, Brian G Feagan. A phase II study of laquinimod in Crohn's diseaseGut 2015; 64(8): 1227 doi: 10.1136/gutjnl-2014-307118
14
Nelson Carrillo. Gallbladder Polyps, Surgical Indications According to their Size and MorphologyGastroenterology & Hepatology : Open Access 2015; 2(2) doi: 10.15406/ghoa.2015.02.00035
15
Jun-Seop Shin, Jung-Sik Kim, Jong-Min Kim, Jae-Yool Jang, Yong-Hee Kim, Hyun-Je Kim, Chung-Gyu Park. Minimizing immunosuppression in islet xenotransplantationImmunotherapy 2014; 6(4): 419 doi: 10.2217/imt.14.14
16
Angelo V. Marzano, Alessandro Borghi, Pier Luigi Meroni, Carlo Crosti, Massimo Cugno. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapyAutoimmunity 2014; 47(3): 146 doi: 10.3109/08916934.2013.873414
17
Carlos S.M. Bezerra-Filho, Joice N. Barboza, Marilia T.S. Souza, Peter Sabry, Nasser S.M. Ismail, Damião P. de Sousa. Therapeutic Potential of Vanillin and its Main Metabolites to Regulate the Inflammatory Response and Oxidative StressMini-Reviews in Medicinal Chemistry 2019; 19(20): 1681 doi: 10.2174/1389557519666190312164355
18
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine2018; : 1 doi: 10.1007/978-3-319-28100-1_9-1
19
Sang Hyoung Park, Young-Ho Kim, Ji Hyun Lee, Hyeok Jin Kwon, Suck-Ho Lee, Dong Il Park, Hyung Kil Kim, Jae Hee Cheon, Jong Pil Im, You Sun Kim, Sung Young Lee, Sang Joon Lee. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in KoreaExpert Review of Gastroenterology & Hepatology 2015; 9(sup1): 35 doi: 10.1586/17474124.2015.1091309
20
Ting Zhang, Qian-Yun Lin, Jia-Xi Fei, Yan Zhang, Min-Yi Lin, Shuang-Hong Jiang, Pu Wang, Ye Chen. Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel DiseaseScientific Reports 2016; 6(1) doi: 10.1038/srep29791